Matera, Maria Gabriella
Matera, Maria Gabriella
A review of the safety of antibody therapy in severe eosinophilic asthma
2025-12-24 Matera, Mg; De Novellis, V; Rogliani, P; Cazzola, M
An update on long-acting muscarinic agents for asthma therapy
2025-05-01 Matera, Mg; Cazzola, M; Rogliani, P; Patella, V
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials
2023-01-01 Cazzola, M; Rogliani, P; Barnes, Pj; Blasi, F; Celli, B; Hanania, Na; Martinez, Fj; Miller, Be; Miravitlles, M; Page, Cp; Tal-Singer, R; Matera, Mg
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences
2024-01-01 Cazzola, M; Page, Cp; Hanania, Na; Calzetta, L; Matera, Mg; Rogliani, P
Biologics for severe asthma: deciphering what is best for the patient
2025-08-01 Cazzola, M; Hanania, Na; Matera, Mg; Rogliani, P
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database
2024-01-01 Cazzola, M; Matera, Mg; Calzetta, L; Lauro, D; Rogliani, P
Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications
2023-01-01 Cazzola, M; Hanania, Na; Rogliani, P; Matera, Mg
Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes
2025-10-01 Cazzola, M; Maniscalco, M; Patella, V; Calzetta, L; Matera, Mg; Rogliani, P
Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022
2023-01-01 Stolz, D; Matera, Mg; Rogliani, P; van den Berge, M; Papakonstantinou, E; Gosens, R; Singh, D; Hanania, N; Cazzola, M; Maitland-Van der Zee, A-; Fregonese, L; Mathioudakis, Ag; Vestbo, J; Rukhadze, M; Page, Cp
Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits
2025-09-03 Cazzola, M; Mcdonald, Vm; Stolz, D; Rogliani, P; Matera, Mg
Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary Disease
2025-01-01 Cazzola, M; Matera, Mg; Hanania, N; Rogliani, P
Evaluating tezepelumab for COPD: a missed target or unmet potential?
2025-01-01 Cazzola, M; Rogliani, P; Matera, Mg
Hyperglycaemia and Chronic Obstructive Pulmonary Disease
2023-01-01 Cazzola, M; Rogliani, P; Ora, J; Calzetta, L; Lauro, D; Matera, Mg
Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD)
2020-01-01 Calzetta, L; Ritondo, Bl; Matera, Mg; Pezzuto, G; Cazzola, M; Rogliani, P
Metabolomics application for the design of an optimal diet
2022-10-17 Naureen, Z; Cristoni, S; Donato, K; Medori, Mc; Samaja, M; Herbst, Kl; Aquilanti, B; Velluti, V; Matera, G; Fioretti, F; Iaconelli, A; Perrone, Ma; Di Giulio, L; Gregorace, E; Chiurazzi, P; Nodari, S; Connelly, St; Bertelli, M
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?
2023-01-01 Cazzola, M; Rogliani, P; Matera, Mg
Revisiting asthma pharmacotherapy: where do we stand and where do we want to go?
2023-01-01 Cazzola, M; Page, Cp; Matera, Mg; Rogliani, P; Hanania, Na
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials
2023-01-01 Cazzola, M; Page, C; Calzetta, L; Singh, D; Rogliani, P; Matera, Mg
β-Blockers and Asthma: Surprising findings from the FAERS database
2024-01-01 Cazzola, M; Ora, J; Calzetta, L; Rogliani, P; Matera, Mg
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 24-dic-2025 | A review of the safety of antibody therapy in severe eosinophilic asthma | Matera, Mg; De Novellis, V; Rogliani, P; Cazzola, M | Articolo su rivista | |
| 1-mag-2025 | An update on long-acting muscarinic agents for asthma therapy | Matera, Mg; Cazzola, M; Rogliani, P; Patella, V | Articolo su rivista | |
| 1-gen-2023 | An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials | Cazzola, M; Rogliani, P; Barnes, Pj; Blasi, F; Celli, B; Hanania, Na; Martinez, Fj; Miller, Be; Miravitlles, M; Page, Cp; Tal-Singer, R; Matera, Mg | Articolo su rivista | |
| 1-gen-2024 | Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences | Cazzola, M; Page, Cp; Hanania, Na; Calzetta, L; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 1-ago-2025 | Biologics for severe asthma: deciphering what is best for the patient | Cazzola, M; Hanania, Na; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 1-gen-2024 | Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database | Cazzola, M; Matera, Mg; Calzetta, L; Lauro, D; Rogliani, P | Articolo su rivista | |
| 1-gen-2023 | Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications | Cazzola, M; Hanania, Na; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-ott-2025 | Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes | Cazzola, M; Maniscalco, M; Patella, V; Calzetta, L; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 1-gen-2023 | Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022 | Stolz, D; Matera, Mg; Rogliani, P; van den Berge, M; Papakonstantinou, E; Gosens, R; Singh, D; Hanania, N; Cazzola, M; Maitland-Van der Zee, A-; Fregonese, L; Mathioudakis, Ag; Vestbo, J; Rukhadze, M; Page, Cp | Articolo su rivista | |
| 3-set-2025 | Emerging Therapeutics in COPD: Mapping Innovation to Treatable Traits | Cazzola, M; Mcdonald, Vm; Stolz, D; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2025 | Established and Emerging Biological Therapies for the Treatment of Comorbid Asthma and Chronic Obstructive Pulmonary Disease | Cazzola, M; Matera, Mg; Hanania, N; Rogliani, P | Articolo su rivista | |
| 1-gen-2025 | Evaluating tezepelumab for COPD: a missed target or unmet potential? | Cazzola, M; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2023 | Hyperglycaemia and Chronic Obstructive Pulmonary Disease | Cazzola, M; Rogliani, P; Ora, J; Calzetta, L; Lauro, D; Matera, Mg | Articolo su rivista | |
| 1-gen-2020 | Investigational treatments in phase I and II clinical trials: a systematic review in chronic obstructive pulmonary disease (COPD) | Calzetta, L; Ritondo, Bl; Matera, Mg; Pezzuto, G; Cazzola, M; Rogliani, P | Articolo su rivista | |
| 17-ott-2022 | Metabolomics application for the design of an optimal diet | Naureen, Z; Cristoni, S; Donato, K; Medori, Mc; Samaja, M; Herbst, Kl; Aquilanti, B; Velluti, V; Matera, G; Fioretti, F; Iaconelli, A; Perrone, Ma; Di Giulio, L; Gregorace, E; Chiurazzi, P; Nodari, S; Connelly, St; Bertelli, M | Articolo su rivista | |
| 1-gen-2023 | Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Cazzola, M; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2023 | Revisiting asthma pharmacotherapy: where do we stand and where do we want to go? | Cazzola, M; Page, Cp; Matera, Mg; Rogliani, P; Hanania, Na | Articolo su rivista | |
| 1-gen-2023 | What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials | Cazzola, M; Page, C; Calzetta, L; Singh, D; Rogliani, P; Matera, Mg | Articolo su rivista | |
| 1-gen-2024 | β-Blockers and Asthma: Surprising findings from the FAERS database | Cazzola, M; Ora, J; Calzetta, L; Rogliani, P; Matera, Mg | Articolo su rivista |